Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 5
1990 4
1991 7
1992 5
1993 1
1994 5
1995 3
1996 7
1997 3
1998 7
1999 4
2000 5
2001 4
2002 10
2003 6
2004 8
2005 3
2006 2
2007 5
2008 4
2009 7
2010 6
2011 9
2012 9
2013 7
2014 11
2015 16
2016 18
2017 12
2018 17
2019 22
2020 20
2021 18
2022 18
2023 11
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Free article. Clinical Trial.
[Endometriosis and malignoma].
Ulrich U, Richter O, Wardelmann E, Valter M, Schmutzler R, Sillem M, Possover M, Mallmann P. Ulrich U, et al. Among authors: mallmann p. Zentralbl Gynakol. 2003 Jul-Aug;125(7-8):239-42. doi: 10.1055/s-2003-42277. Zentralbl Gynakol. 2003. PMID: 14505256 Review. German.
Genomic Signatures in Luminal Breast Cancer.
Puppe J, Seifert T, Eichler C, Pilch H, Mallmann P, Malter W. Puppe J, et al. Among authors: mallmann p. Breast Care (Basel). 2020 Aug;15(4):355-365. doi: 10.1159/000509846. Epub 2020 Jul 21. Breast Care (Basel). 2020. PMID: 32982645 Free PMC article. Review.
Tumor vaccination.
Mallmann P. Mallmann P. Hybridoma. 1995 Apr;14(2):187-90. doi: 10.1089/hyb.1995.14.187. Hybridoma. 1995. PMID: 7590778 Review.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on the Use of Primary Chemoimmunotherapy to Treat Patients with Locally Advanced or Recurrent Endometrial Cancer.
Tempfer C, Brucker S, Juhasz-Boess I, Mallmann P, Steiner E, Denschlag D, Hillemanns P, Wallwiener M, Beckmann MW; Uterus Commission of the AGO. Tempfer C, et al. Among authors: mallmann p. Geburtshilfe Frauenheilkd. 2023 Sep 12;83(9):1095-1101. doi: 10.1055/a-2145-1545. eCollection 2023 Sep. Geburtshilfe Frauenheilkd. 2023. PMID: 38230409 Free PMC article.
289 results